Israeli biotech Glycominds has reported that it has discovered a method for predicting clinical episodes in people who suffer from multiple sclerosis.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000651911&fid=1725
MS test successful
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.